Serum AZD7442 (tixagevimab-cilgavimab) concentrations and in vitro IC 50 values predict SARS-CoV-2 neutralising antibody titres.

Lindsay E CleggOleg StepanovSam MatthewsTom WhiteSeth SeegobinSteven ThomasKevin M TuffyMats NågårdMark T EsserKatie StreicherTaylor S CohenAnastasia A Aksyuk

Published in: Clinical & translational immunology (2024)

values can be used to rapidly predict nAb titres in serum for emerging and historical SARS-CoV-2 variants.

Keyphrases

sars cov
respiratory syndrome coronavirus
copy number
gene expression